# Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients.

> PubMed lists PMID 30565376 in Diabetes, obesity & metabolism as Journal Article, with publication-date metadata of 2019-01-20 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30565376-dulaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30565376-dulaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-30565376-dulaglutide-v1.json
- Content SHA-256: `88ac9fb4b2bbdba54fcf1e35988708158a1c8f8d7b1fa5f7eb4394d55bd46e7e`

## Claims and source pins

### Headline

Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients. ([`pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de`](#source-pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de))

### Summary

PubMed lists PMID 30565376 in Diabetes, obesity & metabolism as Journal Article, with publication-date metadata of 2019-01-20 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de`](#source-pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de))

### Paragraph 1

PubMed lists PMID 30565376 in Diabetes, obesity & metabolism as Journal Article, with publication-date metadata of 2019-01-20 (day precision). PeptideScanner associated the retained record with the identity slug dulaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de`](#source-pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de`](#source-pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de))

## Sources

<a id="source-pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de"></a>
- **Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients. · retained source version 1:2026-01-27:current:146cd4f420de4e52ab70787dcdace04b192b07a912e4bcda9231f7409a90a891** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30565376/) (`pubmed-observation-pmid-30565376-2026-01-27-146cd4f420de`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Largest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-30565376-dulaglutide-v1.json SHA-256: 88ac9fb4b2bbdba54fcf1e35988708158a1c8f8d7b1fa5f7eb4394d55bd46e7e.